Sebastian Wanless
Corporate Officer/Principal at TCB Newco Ltd.
Sebastian Wanless active positions
| Companies | Position | Start | End |
|---|---|---|---|
TCB Newco Ltd.
 TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Corporate Officer/Principal | - | - |
Career history of Sebastian Wanless
Former positions of Sebastian Wanless
| Companies | Position | Start | End |
|---|---|---|---|
| TC BIOPHARM (HOLDINGS) PLC | Corporate Officer/Principal | 01/09/2020 | 01/09/2022 |
| Bristol-Myers Squibb Foundation | Corporate Officer/Principal | 01/01/2003 | 01/01/2007 |
Statistics
International
| United Kingdom | 3 |
| United States | 2 |
Operational
| Corporate Officer/Principal | 3 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| TC BIOPHARM (HOLDINGS) PLC | Health Technology |
| Private companies | 2 |
|---|---|
TCB Newco Ltd.
TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Health Technology |
| Bristol-Myers Squibb Foundation |
- Stock Market
- Insiders
- Sebastian Wanless
- Experience
